NCT05038306View on ClinicalTrials.gov

Chinese Medicine WT for Spinocerebellar Ataxia Type 3

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

September 26, 2022

Study Completion Date

September 26, 2022

Conditions
Ataxia, SpinocerebellarInsulin-Like Growth Factor IMedicine, Chinese Traditional
Interventions
DRUG

Chinese medicine WT

The Chinese medicine WT is thought to be neurotrophic, and its major constituent may benefit IGF-1 in animal studies, or certain healthy human group. WT is safe in clinical use in Asia.

Trial Locations (1)

500

Changhua Christian Hospital, Changhua

All Listed Sponsors
lead

Changhua Christian Hospital

OTHER